Results 111 to 120 of about 2,997 (148)

Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability [PDF]

Objective Investigate whether hyoscine patch or glycopyrronium liquid is more effective and acceptable to treat drooling in children with neurodisability.Design Multicentre, single-blind, randomised controlled trial.Setting Recruitment through ...
Cole M, Parr JR, Pennington L, Todhunter E, Tuffrey C, O'Hare AE, Williams J, Cadwgan J, Colver AF, Stocken D   +9 more
core  

A Study on the Use of Nebulized Glycopyrronium in Hospitalized Patients With Exacerbations of Obstructive Airway Disease. [PDF]

Cureus
Khanna A, Tandon A, Narasimhan R L.
europepmc   +1 more source

Profiles and Disease Burden of Patients with COPD Initiating Triple Therapy in China. [PDF]

Int J Chron Obstruct Pulmon Dis
Li X, Cao J, Hao S, Noorduyn SG, Tang Z, Ismaila AS, Chen I, Ding J.   +7 more
europepmc   +1 more source

Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study. [PDF]

Pulm Ther
Alcázar-Navarrete B, Figueira-Gonçalves JM, Blanco Cid N, Bruguera Avila N, Bernabeu Mora R, Fuster Gomila A, Galera Martínez R, García Clemente MM, Granados G, Khadour Khadour H, Márquez-Martín E, Murga Arizabaleta I, Velasco Garrido JL, Corregidor-García C, Fitas E, Sánchez-Covisa J.   +15 more
europepmc   +1 more source

Real-world evaluation of adherence to single-inhaler triple therapy in chronic obstructive pulmonary disease: the LIFE Study. [PDF]

Respir Res
Ogata H, Tsubouchi K, Takano T, Maeda M, Oda F, Okamoto I, Fukuda H.   +6 more
europepmc   +1 more source

Efficacy of single-inhaler triple therapies for chronic obstructive pulmonary disease: a systematic review and network meta-analysis. [PDF]

BMC Pulm Med
Zhang Y, Zhao P, Zhang Y.
europepmc   +1 more source

Letter to the Editor Regarding "Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study". [PDF]

Adv Ther
Golpe R.
europepmc   +1 more source

Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Rebordosa C, Aguado J, Bartsch J, Saigi-Morgui N, Carsin AE, Garcia-Esteban R, Ignatova E, Freedman D, Perez-Gutthann S, Rivero-Ferrer E.   +9 more
europepmc   +1 more source

Percutaneous endoscopic gastrostomy insertion in patients with neuromuscular disease-a single centre experience of a novel technique. [PDF]

Front Gastroenterol (Lausanne)
Faher A, Gunn M, Williams TL, Dipper C, McGowan L, Rimmer C, Messer B.   +6 more
europepmc   +1 more source

Response to: Letter to the Editor Regarding 'Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study'. [PDF]

Adv Ther
Alcázar-Navarrete B, Figueira-Gonçalves JM, Corregidor-García C, Fitas E, Sánchez-Covisa J.   +4 more
europepmc   +1 more source